Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Want to earn money instantly? Check out these quick ideas that can help you boost your income right away.
11,250 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A major healthcare-focused fund just nudged its bets into a wearable heart-monitor company. This move spotlights the ...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
Spring 2026 opens with renewed urgency as loan costs rise and builders push incentives. The market watches mortgage r...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...
A KRW-backed stablecoin and offshore perpetual futures contract launch in April 2026, signaling Wall Street’s push to...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
In a world of market swings, a simple, broad-based approach can anchor your portfolio. The Vanguard Total Stock Marke...
As 2026 nears, one stock stands out for investors: the company that’s about to launch the year’s first blockbuster st...
A UC Berkeley analysis tracking households through 2025 finds relocating out of California reduces monthly housing bi...